Nasal Delivery Technology, Quality By Design Processes And Outsourcing Considerations

Catalent leverages decades of experience in the development, evaluation and manufacture of inhalation products to advance and accelerate molecules, from early development through commercial manufacturing. Catalent’s operation integrates its knowledge and experience to reliably deliver therapies across all common inhalation dosage forms including MDI, DPI and nasal sprays.

This eBook features articles discussing the advantages of unit/bi-dose nasal delivery technology, application of quality by design (QbD) process for inhaled product development and why companies are looking to outsource inhalation development and manufacturing.